In intraday trading this Monday, the Ibovespa was up 0.91% at 172,585.61 points, while Oncoclínicas (ONCO3) was quoted at R$ 1.58, up 37.39%, and Ambipar (AMBP3) was trading at R$ 0.15, down 6.25%. Compared with earlier readings in the session, ONCO3 had reduced the previously observed move but remained the day’s biggest gainer, and the Ibovespa was also showing a smaller gain than recorded at earlier points in the day.
Among the top gainers, besides Oncoclínicas, Paranapanema (PMAM3) was at R$ 0.15, advancing 15.38%. Yduqs (YDUQ3) was up 12.45%, quoted at R$ 8.85, after recent news of initial talks with Afya for a possible business combination, still without any agreement or binding commitment. Azevedo & Travassos Energia (AZTE3) was trading at R$ 1.57, up 8.28%, while Armac (ARML3) was at R$ 3.56, with a 7.88% gain at the same time.
On the losing side, Ambipar remained the session’s biggest decliner, with AMBP3 at R$ 0.15, down 6.25%. Braskem (BRKM5) fell 5.33% to R$ 4.80 after, in recent days, having approved a request for out-of-court reorganization involving unsecured debts of around US$ 10.9 billion. Among the other notable losers, Biomm (BIOM3) was quoted at R$ 6.35, down 3.79%, Brava Energia (BRAV3) retreated 3.72% to R$ 18.10, and Arezzo (AZZA3) was trading at R$ 14.74, down 2.64%.
Over the course of the session, the behavior of the main movers changed compared with the first hours of trading, when the Ibovespa at one point dipped into negative territory and other stocks figured among the biggest moves. At the time of the latest data, however, ONCO3 was still the top percentage gainer of the day and AMBP3 appeared at the other end of the table, among the biggest losers on B3.
See also:
